NABI /DE/
424B3, 1997-12-30
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NL INDUSTRIES INC, 8-K, 1997-12-30
Next: OHIO NATIONAL VARIABLE ACCOUNT A, N-4, 1997-12-30



<PAGE>   1
PROSPECTUS SUPPLEMENT                           Filed pursuant to Rule 424(b)(3)
To Prospectus Dated May 3, 1996,                       Registration No. 333-2253
As Supplemented to Date



                                  $80,500,000

                                      NABI

                 6 1/2% Convertible Subordinated Notes due 2003
                                      and
               Shares of Common Stock, Par Value $.10 Per Share,
                        Issuable Upon Conversion Thereof

         This Prospectus Supplement (the "Supplement") relates to the resale by
BancAmerica Robertson Stephens ("BancAmerica") of up to $2,660,000 aggregate
principal amount of 6 1/2% Convertible Subordinated Notes due 2003 (the "Notes")
of NABI, a Delaware corporation (the "Company"), originally issued in private
placements consummated on February 7 and March 6, 1996 (the "Debt Offering"),
pursuant to NABI's Registration Statement on Form S-3 (No. 333-2253) (the
"Registration Statement"). This Supplement should be read in conjunction with
the Prospectus dated May 3, 1996, as supplemented to date (the "Prospectus"), to
be delivered with this Supplement. All capitalized terms used but not defined in
this Supplement shall have the meanings given them in the Prospectus.

         Based on information provided to the Company, the aggregate principal
amount of the Notes that are currently beneficially owned by BancAmerica is
$2,660,000 all of which may be sold at this time pursuant to the Prospectus as
supplemented hereby. Additional information concerning the Selling
Securityholders (including BancAmerica) may be set forth from time to time in
additional supplements to the Prospectus. The total outstanding aggregate
principal amount of the Notes is $80,500,000.

         The closing price of the Company's Common Stock as reported on The
Nasdaq National Market on December 19, 1997 was $3.63 per share.

         The Notes will be subordinated to all existing and future Senior
Indebtedness of the Company. At August 31, 1997, Senior Indebtedness was
approximately $25,200,000. The Indenture contains no limitations on the
incurrence of additional indebtedness or other liabilities by the Company.

         The Notes are neither listed on a national securities exchange nor
quoted on an automated quotation system. However, the Notes are eligible for
trading in the Private Offerings, Resales and Trading through Automated Linkages
("PORTAL") Market. Notes sold pursuant to the Registration Statement will no
longer be eligible for trading in the PORTAL Market.

          The date of this Prospectus Supplement is December 22, 1997.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission